Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis

Completed · Phase 2

Conditions studied: Plaque Psoriasis

In brief

The objective of the study is to evaluate the safety and efficacy of a topical lotion

Key facts

Study ID

NCT02045277

Run by

Bausch Health Americas, Inc.

People needed

212

Starts

2014-02-01

Expected to finish

2014-11-01

Last updated by the study team

2020-08-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Valeant Site 13 — Encino, California, United States
• Valeant Site 11 — San Diego, California, United States
• Valeant Site 15 — Santa Rosa, California, United States
• Valeant Site 10 — Augusta, Georgia, United States
• Valeant Site 09 — Newnan, Georgia, United States
• Valeant Site 08 — Louisville, Kentucky, United States
• Valeant Site 04 — Rockville, Maryland, United States
• Valeant Site 14 — Clinton Township, Michigan, United States
• Valeant Site 07 — Fridley, Minnesota, United States
• Valeant Site 01 — East Windsor, New Jersey, United States
• Valeant Site 03 — New York, New York, United States
• Valeant Site 17 — Rochester, New York, United States
• Valeant Site 02 — High Point, North Carolina, United States
• Valeant Site 05 — Austin, Texas, United States
• Valeant Site 06 — College Station, Texas, United States
• Valeant Site 16 — Salt Lake City, Utah, United States
• Valeant Site 18 — Lynchburg, Virginia, United States
• Valeant Site 12 — Norfolk, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.